For example, the inhibition of HIF1α increases the sensitivity of GBM cells to chemotherapeutic drugs27 and a strategy targeting HIF2α in GSCs attenuated the tumour initiation potential5,28. This evidence concerns the gene EPAS1 and neoplasm.